Author(s):
Gunjan P. Malode, Dhiraj V. Yawale, Yogesh D. Chainani, Ashwini S. Meshram, Neha A. Badukale, Dhanashree N. Sarwan
Email(s):
gunjangadge14@gmail.com
DOI:
10.52711/2231-5713.2025.00058 
Address:
Gunjan P. Malode*1, Dhiraj V. Yawale1, Yogesh D. Chainani1, Ashwini S. Meshram2, Neha A. Badukale3, Dhanashree N. Sarwan4
1IBSS’s Dr. Rajendra Gode Institute of Pharmacy, Amravati - 444 602, MS, India.
2Anurag College of Pharmacy, Warthi, Bhandara - 441905, MS, India.
3IBSS’s Dr. Rajendra Gode College of Pharmacy, Amravati - 444 602, MS, India.
4Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaja Nagpur University Nagpur Maharashtra India - 440033.
*Corresponding Author
Published In:
Volume - 15,
Issue - 4,
Year - 2025
ABSTRACT:
The advancement of co-processed excipients has significantly enhanced pharmaceutical formulation development, particularly in direct compression tablet manufacturing. Co-processed excipients are a synergistic combination of two or more established excipients designed to improve physical and mechanical properties without altering their chemical composition. These excipients address challenges such as poor flowability, compressibility, and stability often encountered with conventional materials. Innovations in co-processing techniques, such as spray drying, melt extrusion, and solvent evaporation, enable the creation of multifunctional excipients tailored for specific applications. Key advantages of co-processed excipients include improved compressibility, better flow properties, reduced sensitivity to lubricants, and enhanced dilution potential, which collectively simplify the manufacturing process and improve tablet quality. Additionally, co-processing eliminates the need for complex blends of multiple excipients, thereby reducing production costs and minimizing formulation errors. Examples such as Cellactose, Ludipress, and Avicel CE-15 demonstrate superior performance in applications requiring high-speed tableting and fast disintegration. Despite their benefits, the development of co-processed excipients faces challenges like high production costs, material losses, and compatibility issues with thermolabile APIs. However, ongoing research in optimizing co-processing techniques and leveraging novel combinations is expected to drive future advancements. With increasing demands for innovative excipient solutions, co-processed excipients hold promise for transforming pharmaceutical formulation practices and achieving greater efficiency, consistency, and functionality in drug delivery systems.
Cite this article:
Gunjan P. Malode, Dhiraj V. Yawale, Yogesh D. Chainani, Ashwini S. Meshram, Neha A. Badukale, Dhanashree N. Sarwan. A Reveiw: Development on Co-Processed Excipients used in Current and Future Trend of Excipient Technology. Asian Journal of Pharmacy and Technology. 2025; 15(4):405-1. doi: 10.52711/2231-5713.2025.00058
Cite(Electronic):
Gunjan P. Malode, Dhiraj V. Yawale, Yogesh D. Chainani, Ashwini S. Meshram, Neha A. Badukale, Dhanashree N. Sarwan. A Reveiw: Development on Co-Processed Excipients used in Current and Future Trend of Excipient Technology. Asian Journal of Pharmacy and Technology. 2025; 15(4):405-1. doi: 10.52711/2231-5713.2025.00058 Available on: https://ajptonline.com/AbstractView.aspx?PID=2025-15-4-11
REFERENCE:
1. Chaudhari PD, Phatak AA, Desai U. A review: co processed excipients-an alternative to novel chemical entities. International Journal of Pharmaceutical and Chemical Sciences. 2012 Oct, 1(4): 1480-98.
2. Atul P, Subrata K, Ganga S. A review on co-processed excipients: a novel approach in formulation development. IJRAPI. 2013; 3: 25-41.
3. The International Pharmaceutical Excipient Council Excipient Composition Guide. Europe; 2009.
4. Smewing J; Powder flow analysis‐ the solution. Manuf Chem. 2002; 32‐33.
5. Nachegari SK, Bansal AK. Coprocessed excipients for solid dosage forms. Pharm Tech. 2004; 28:52-64.
6. Marwaha M, Sandhu D, Marwaha RK. Coprocessing of excipients: a review on excipient development for improved tabletting performance. Int J Appl Pharm. 2010; 2:41-2.
7. Flores LE, Arellano RL, Esquivel JJD. Study of load capacity of Avicel PH200 and cellactose, two direct compression excipients, using an experimental design. Drug Dev Ind Pharm. 2000; 26:465–9.
8. Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Technol Today. 2000; 3:58-63.
9. Sherwood BE, Becker JW. A new class of high functionality excipients: silicified microcrystalline cellulose. Pharm Tech. 1988; 22:78–88.
10. Pakhale BA, Shinkar DM, Saudagar RB. Co-processed excipient: an overview. World J Pharm Res. 2014; 4:454-69.
11. Ambore SM, Tekale J, Gattani SG. Investigation of novel multifunctional co-processed excipient for direct compression. World Appl Sci J. 2014; 31:801-10.
12. Belda PM, Mielck JB. The tableting behavior of Cellactose compared with mixtures of celluloses with lactoses. Eur J Pharm Biopharma. 1996; 42:325–30.
13. Patel RP, Bhavsar M. Direcetly compressible materials via co-processing. Iran J Pharm Res. 2009; 1:745-53.
14. Reimerdes D. The near future of tablet excipients. Manufact Chem. 1993; 64:14–5.
15. Marwaha M, Sandhu D, Marwaha RK. Coprocessing of excipients: a review on excipient development for improved tableting performance. Int J Appl Pharm. 2010; 2:41-7.
16. Panda B, Raot A, Kilor V. Co-processed excipients: an overview of formulation aspects, physical characteristics, and role as a pharmaceutical aid. Pharmatutor Art. 1049; 2010.
17. Limwong V, Sutanthavibul N, Kulvanich P. Spherical composite particles of rice starch and microcrystalline cellulose: a new co-processed excipient for direct compression. AAPS PharmSciTech. 2004; 5:40-9.
18. Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Preparation and assessment of novel co-processed superdisintegrant consisting of crospovidone and sodium starch glycolate: a technical note. AAPS PharmSciTech 2007; 8:63-9.
19. Jacob S, Shirwaikar AA, Joseph A, Srinivasan KK. Novel coprocessed excipients of mannitol and microcrystalline cellulose for preparing fast dissolving tablets of glipizide. Indian J Pharm Sci. 2007; 69:633-9.
20. Barakat NS, Elbagory IM, Almurshedi AS. Controlled release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. Drug Delivery. 2009; 16:57-65.
21. Hebestreit Philipp Dr. Pharma Ingredients & Services, BASF, addressing specific regulatory excipient requirements in the marketing authorization, Pharm Sci Fair Nice. June 11th, 2009.
22. Ayyapan J, Umapathi P, Darlin quine. Development and evaluation of a directly compressible Co-processed sustained release agent for tablets. Int J Pharmacy Pharm Sci. 2010; 2: 201-205.
23. Philip F, Bonaventurea BAM, Tiwaladeb A, Okpakoc LC, Attama AA. Novel multifunctional pharmaceutical excipients derived from microcrystalline cellulose–starch micro particulate composites prepared by compatibilized reactive polymer blending. Int J Pharm, 2010; 388: 159–167.
24. Gohel MC, Jogani PD. Exploration of melt granulation technique for the development of co-processed directly compressible adjuvant containing lactose and microcrystalline cellulose. Pharm Dev Technol, 2003; 8: 175–185.
25. Pawar SB, Ahirrao SP, Kshirsagar SJ, City BK, Knowledge B. Review on novel pharmaceutical co-processed excipients. Pharm. Reson. 2019, 2:14-20.
26. Bone A, Izebound E. Excipients on the move. IPEC Europe news. Available from: http://www.ipec-europe.org/UPLOADS/ 2004_October.pdf. [Last accessed on 15 Aug 2015].
27. Patel RP, Patel MP, Suthar AM. Spray drying technology: an overview. Indian J Sci Technol. 2009; 2:44-5.
28. Bauer KH. Coprocessed polysaccharide product with insolublecarboxymethylcellulose. EP1070740, 2001.
29. Bauer K, Streb M. Coprocessed granules of disintegrating agents. EP1201709; 2002.
30. Hapgood KP, Tan MXL, Chow DWY. A method to predict nuclei size distributions for use in models of wet granulation. Adv Powder Technol. 2009; 20:293–7.
31. York FP, Rowe RC. Process control and scale-up of pharmaceutical wetgranulation processes: a review. Eur J Pharm Biopharm. 2000; 52:269–77.
32. Bin LK, Gaurav A, Mandal UK. A review on co-processed excipients: current and future trend of excipient technology. Int J Pharm Sci. 2019.
33. Bin LK, Hui HS, Uddin AH, Sarker ZI, Ling CY. Co-processed Excipients: A Revisit of Its Development in the Past Two Decades, A Review. Journal of Pharmaceutical Negative Results. 2022 Oct 11:96-103.
34. Liu JP, Zhang F, McGinity JW. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot melt extrusion. Eur J Pharm Biopharm. 2001; 52:181-90
35. Bin LK, Hui HS, Uddin AH, Sarker ZI, Ling CY. Co-processed Excipients: A Revisit of Its Development in the Past Two Decades, A Review. Journal of Pharmaceutical Negative Results. 2022 Oct 11:96-103.
36. Smewing J; Powder flow analysis‐ the solution. Manuf Chem. 2002; 32‐33.
37. Patel SS, Patel NM. Development of directly compressible coprocessed excipients for dispersible tablets using 32 full factorial design. Int J Pharmacy Pharm Sci. 2009; 1: 125-148.
38. Gohel MC. Using Methocel cellulose ethers for controlled release of drugs in hydrophilic matrix systems, A review of co-processed directly compressible excipients. J Pharm Sci. 2005; 8: 76–93.
39. Bansal AK and Nachaegari SK. Co processed excipient for solid dosage form. Pharm Technol, 2004; 52-64.
40. Ajay Subhash Chougule, Amrita Dikpati and Tushar Trimbake. Formulation Development Techniques of Co-processed Excipients. Journal of Advanced Pharmaceutical Sciences. 2012; 2(2): 231-249.
41. Chowdary KPR and Ramya K. Recent Research on Co-Processed Excipients for Direct Compression-A Review. International Journal of Comprehensive Pharmacy. 2013; 2(01): 1-5.
42. Shangraw R F, Wallace J W and Bowers F M; Morphology and Functionality in Tablet Excipients for Direct Compression. Pharm Technol. 1987; 11: 136‐143.
43. Bolhuis G K, and Chowhan Z T; Materials for Direct Compression. Pharmaceutical Powder Compaction Technology. Vol‐7, Marcel Dekker, USA, 1996: 419‐49.
44. Reimerdes D and Aufmuth K P; Tabletting with Co‐processed Lactose‐Cellulose Excipients. Manuf Chem. 1992; 63:21‐24.
45. Ibrahim Y K and Olurinola P F; Comparative Microbial Contamination Levels in Wet Granulation and Direct Compression Methods of Tablet Production. Pharm Acta Helv. 1991; 66:298‐301.
46. Russell R; Synthetic Excipients Challenge All-Natural Organics -Offer advantages/Challenges to Developers and Formulators. Pharm Technol. 2004; 27:38-50.
47. Reimerdes D; The Near Future of Tablet Excipients. Manufacturing Chemist. 1993; 64(7):14-15.
48. Zeleznik J A and Renak J; High Functionality Excipients (HFE) –PROSOLV® SMCC as an Effective Strategy for Generic Drug Formulation. Business briefing: Pharmagenerics. 2004.
49. Moreton R C; “Cellulose, Silicified Microcrystalline,” In Hand Book of Pharmaceutical Excipients, Wade V and Weller P J Eds. (Pharmaceutical Press, London). 2009; 110-111.
50. Dev K M; Co-proceseed Microcrystalline Cellulose and Calcium Carbonate and Its Preparation. US Patent No. 4,744,987 to FMC Corporation (Philadelphia, PA), 1988.
51. European Pharmaceutical Manufacturer Magazine. Cellactose 80 filler blender. Vol 2, Issue 8. Available from: http://www.pharmeurope.com/x/guideArchiveArticle.html?id=1038.
52. Plaizier-Vercammen JA, Bossche VD. Evaluation of the tableting properties of a new excipient for direct compression. Drugs Made Ger. 1993; 36:133-7.
53. Prosolv Technical Report. Tableting binder improves production. Penwest Pharmaceuticals, New York, NY. 2001.
54. Ramani RG. Development of novel co-processed excipients for the design and evaluation of fast-dissolving metoclopramide hydrochloride tablets. Department of Pharmaceutical Technology, H.K.E. Society’s College of Pharmacy. 2010;5-105.
55. Awasthi R, Deepak G, Pawar V, Sharma G, Kulkarni GT. Development of directly compressible co-processed excipients for solid dosage forms. Scholars Res Libr. Der Pharmacia Lett. 2010; 2(6): 151-65.
56. Shankar RK, Chowdary KPR, Kumar GV, Srilakshmi KH, Durga KN. Recent research on co-processed excipients for direct compression—a review. Int J Pharm Res Dev. 2012; 4(1): 37-43.
57. Patel SS, Patel NM. Development of directly compressible co-processed excipients for dispersible tablets using 32 full factorial design. Int J Pharm Pharm Sci. 2009; 1(1): 125-48.
58. Chowdary KPR, Israel FS, Satyanarayana AR. Preparation, characterization, and evaluation of starch-PEG 1500 co-processed excipient as directly compressible vehicle in tablet formulations. Pharm Globale IJCP. 2012; 3(11): 1-4.
59. Avachat A, Ahire VJ. Characterisation and evaluation of spray-dried co-processed excipients and their application in solid dosage form. Indian J Pharm Sci. 2007; 69: 85-90.
60. Marwaha M, Sandhu D, Marwaha RK. Coprocessing of excipients: a review on excipient development for improved tabletting performance. Int J Appl Pharm. 2010; 2(3): 41-7.